Clinical trial
A Multicenter, Randomized, Controlled Trial to Evaluate the Efficacy and Safety of Perioperative Vericiguat in Patients Undergoing Cardiovascular Surgery
NCT07594509 is registered in ClinicalTrials.gov with Nanjing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Controlled Trial to Evaluate the Efficacy and Safety of Perioperative Vericiguat in Patients Undergoing Cardiovascular Surgery
- Lead sponsor
- Nanjing Medical University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- May 31, 2026
- Completion date
- December 31, 2030
- Enrollment
- 600 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardio vascular disease, cardiopulmonary bypass